Review
doi: 10.3949/ccjm.64.8.415.
Carvedilol for heart failure: renewed interest in beta blockers
Affiliations
- PMID: 9308217
- DOI: 10.3949/ccjm.64.8.415
Item in Clipboard
Review
Carvedilol for heart failure: renewed interest in beta blockers
Cleve Clin J Med.
1997 Sep.
Free article
Abstract
Although beta blockers were once contraindicated in patients with heart failure, a growing understanding of the role of the sympathetic nervous system in heart failure is rekindling interest in these drugs. In particular, the beta blocker carvedilol is a valuable adjunctive treatment for mild-to-moderate compensated congestive heart failure, regardless of etiology. The utility of carvedilol appears to be related to its specific properties.
Similar articles
-
Beta-blockers in congestive heart failure: the pharmacology of carvedilol, a vasodilating beta-blocker and antioxidant, and its therapeutic utility in congestive heart failure.Adv Pharmacol. 1998;42:611-5. doi: 10.1016/s1054-3589(08)60825-x. Adv Pharmacol. 1998. PMID: 9327976 No abstract available.
-
Carvedilol: the new role of beta blockers in congestive heart failure.Am Fam Physician. 1998 Nov 1;58(7):1627-34, 1641-2. Am Fam Physician. 1998. PMID: 9824960 Review.
-
Carvedilol: a nonselective beta blocking agent with antioxidant properties.Congest Heart Fail. 2002 May-Jun;8(3):173-7, 190. doi: 10.1111/j.1527-5299.2002.00718.x. Congest Heart Fail. 2002. PMID: 12045386 Review.
-
Carvedilol in the treatment of chronic heart failure.Expert Opin Pharmacother. 2001 May;2(5):831-43. doi: 10.1517/14656566.2.5.831. Expert Opin Pharmacother. 2001. PMID: 11336626 Review.
-
Effectiveness of carvedilol alone versus carvedilol + pimobendan for severe congestive heart failure. For the Keio Interhospital Cardiology Study (KICS) Group.Am J Cardiol. 2000 Jun 15;85(12):1495-7; A7. doi: 10.1016/s0002-9149(00)00803-1. Am J Cardiol. 2000. PMID: 10856401 Clinical Trial. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
